Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Two new indolizidine alkaloids, crepidatumines C () and D (), together with crepidine (), isocrepidamine (), and crepidamine () were isolated from the Lindl. ex Paxt. X-ray diffraction experiments established the absolute configurations of known compounds and . The planar structures and relative configurations of new compounds and were elucidated by extensive spectra analysis including HR-ESI-MS, NMR (H, C, H-H COSY, HSQC, HMBC, and NOESY spectra), and the absolute configurations of and were suggested on the basis of possible biosynthetic pathways. The biological results confirmed that isocrepidamine () displayed a potent hypoglycemic effect in vitro without cytotoxicity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749285 | PMC |
http://dx.doi.org/10.3390/molecules24173071 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!